Medivir AB (publ) (LON: 0GP7)
London
· Delayed Price · Currency is GBP · Price in SEK
2.910
+0.040 (1.39%)
Jan 17, 2025, 11:29 AM BST
Medivir AB Revenue
Medivir AB had revenue of 900.00K SEK in the quarter ending September 30, 2024, with 12.50% growth. This brings the company's revenue in the last twelve months to 7.03M, up 27.69% year-over-year. In the year 2023, Medivir AB had annual revenue of 7.63M with 73.16% growth.
Revenue (ttm)
7.03M SEK
Revenue Growth
+27.69%
P/S Ratio
n/a
Revenue / Employee
703.30K SEK
Employees
10
Market Cap
23.81M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.63M | 3.23M | 73.16% |
Dec 31, 2022 | 4.41M | -27.99M | -86.39% |
Dec 31, 2021 | 32.39M | 11.96M | 58.56% |
Dec 31, 2020 | 20.43M | 11.71M | 134.18% |
Dec 31, 2019 | 8.72M | -15.14M | -63.44% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |